BioCentury
ARTICLE | Clinical News

RheothRx: Began a multinational Phase III trial

May 9, 1994 7:00 AM UTC

CytRx Corp. (CYTR), Norcross, Ga. Product: RheothRx, a tripolymer that coats blood cells, making them slippery and more able to slide past clots Indication: Limit heart damage in heart attacks Status:...